Elanco Records 11% Growth in 3T and Revises Projections
4 Articles
4 Articles
Elanco Health Animal registered revenue of US$ 1,265 billion in the third quarter of 2026, closed on September 30, growth of 11% compared to the same period last year. In organic terms, considering constant exchange rates and excluding the effects of the acquisition of AHV International and of specific revenues transferred to third parties, the advance was 9%. The result reflects the strength of the company's innovation portfolio, growth in the …
Forbes, the world's most renowned business and economic magazine. For Jeff Simmons, Global CEO of Elanco, the performance reflects the advancement of business in the pet market and production animals The post Elanco Invoice US$ 1.3 Billion in the 3rd Quarter and High Guidance for 2026 apareceu primeiro em Forbes Brasil.
Company recorded revenue of $1.26 billion between July and September, high of 11% in the annual comparison, and raised financial projections to 2026
Coverage Details
Bias Distribution
- 100% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium




